UK issues guidance on vigilance reporting of cardiac ablation catheters
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency has issued draft guidance advising manufacturers of CE-marked cardiac ablation catheters on how to report adverse events involving their products under the Medical Devices Vigilance System1.